Nashville, Tenn.-based HCA Healthcare reported collecting 21,137 pounds of unused or expired medications during its sixth annual "Crush the Crisis" national prescription drug take-back event. 

Many hospitals across the nation rely on the 340B program to stay afloat amid challenging financial times. But that could change significantly in the next few years.

The FDA granted accelerated approved to the first gene therapy directly administered into the brain on Nov. 14.

As CVS, Walgreens and Rite Aid close hundreds of pharmacies across the U.S. to cut costs, health systems are finding opportunities in these new pharmacy deserts, WXXI reported Nov. 19. 

In an unconventional push to expand coverage for weight loss medications, Eli Lilly representatives recently visited the New Jersey State Policemen's Benevolent Association to promote their drug Zepbound with a goal to convince that organization of the long-term cost savings associated with obesity treatment, The Wall Street Journal reported Nov. 19. 

CVS Health has become the first organization to receive the Health Equity Accreditation from URAC, an independent accrediting body, for its efforts to address health disparities, according to a Nov. 19 news release from the company. 

A new survey from Wolters Kluwer Health reveals how changes in the pharmacy and retail healthcare environment are influencing consumer attitudes and behaviors toward medication access and care. 

Cook Children's Health Care System, based in Fort Worth, Texas, has won a national award for significantly reducing vaccine-related errors, according to a news release shared with Becker's. 

Eli Lilly announced results from a Phase 2 trial of muvalapin, an experimental drug aimed at lowering lipoprotein(a), a genetically inherited form of cholesterol linked to heart disease. 

As President-elect Donald Trump prepares to take office, the future of Medicare's drug price negotiation program, part of the 2022 Inflation Reduction Act, is uncertain, Roll Call reported Nov. 15. 

Johnson & Johnson and Eli Lilly both sued the federal government this month over the future of their respective 340B drug rebate plans.

The FDA has implemented new rules for TV and radio drug ads, effective Nov. 20, aimed at making the advertisements more clear and direct in explaining medication risks and side effects, The Sun reported Nov. 15. 

As health systems and hospitals implement AI-powered technologies into daily workflows — such as ambient listening and drafting patient portal messages — pharmacy departments are also exploring AI's capabilities.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13. 

A six-month shortage of cisplatin, a drug used in the treatment of head and neck cancer, resulted in a 16% total cost increase for practices in the U.S. Oncology Network, according to a study presented Sept. 27-28, at the American Society of Clinical Oncology's 2024 Quality Care Symposium in San Francisco.

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated with tirzepatide remained diabetes-free by the end of the study. 

The FDA continues to face significant staffing shortages in its drug inspection workforce, according to a new report from the Government Accountability Office. 

The FDA has rejected the supplemental new drug application for Ocaliva, a treatment for primary biliary cholangitis, a rare liver disease. 

As retail pharmacy giants such as CVS, Walgreens and Rite Aid close stores across the U.S., the consequences for patient care and the impact on the pharmacy industry are becoming more apparent. 

Here are nine new drug shortages to know, according to databases compiled by the FDA and the American Society of Health-System Pharmacists.